MarketBeat Instant News Alerts 2 hours agoCelcuity (NASDAQ:CELC) Price Target Cut to $134.00 by Analysts at Needham & Company LLCMarketBeatNeedham & Company LLC decreased their target price on Celcuity from $140.00 to $134.00 and set a "buy" rating for the company in a research report on Wednesday.NASDAQ:CELCRead Celcuity (NASDAQ:CELC) Price Target Cut to $134.00 by Analysts at Needham & Company LLC2 hours agoConcentrix (NASDAQ:CNXC) Stock Keeps Buy Rating at Canaccord Genuity GroupMarketBeatCanaccord Genuity Group restated a "buy" rating and set a $45.00 price objective on shares of Concentrix in a report on Wednesday.NASDAQ:CNXCRead Concentrix (NASDAQ:CNXC) Stock Keeps Buy Rating at Canaccord Genuity Group2 hours agoJohn B. Sanfilippo & Son (NASDAQ:JBSS) Given Buy Rating at BWS FinancialMarketBeatBWS Financial reissued a "buy" rating and set a $109.00 target price on shares of John B. Sanfilippo & Son in a research note on Wednesday.NASDAQ:JBSSRead John B. Sanfilippo & Son (NASDAQ:JBSS) Given Buy Rating at BWS Financial2 hours agoKenon (NYSE:KEN) Stock Price Down 5.5% - Here's What HappenedMarketBeatKenon (NYSE:KEN) Stock Falls 5.5% - Time to Sell?NYSE:KENRead Kenon (NYSE:KEN) Stock Price Down 5.5% - Here's What Happened2 hours agoBraveheart Bio (NASDAQ:BRVE) Shares Down 7.3% - Here's What HappenedMarketBeatBraveheart Bio (NASDAQ:BRVE) Stock Price Down 7.3% - Here's WhyNASDAQ:BRVERead Braveheart Bio (NASDAQ:BRVE) Shares Down 7.3% - Here's What Happened2 hours agoFranco-Nevada (NYSE:FNV) Shares Down 8.4% - Should You Sell?MarketBeatFranco-Nevada (NYSE:FNV) Stock Price Down 8.4% - What's Next?NYSE:FNVRead Franco-Nevada (NYSE:FNV) Shares Down 8.4% - Should You Sell? Trending News1Aurora Innovation (NASDAQ:AUR) Shares Down 6.7% - Here's Why2Intel (NASDAQ:INTC) Shares Down 5.7% - Here's Why3Intel (NASDAQ:INTC) Stock Falls 3.4% - Here's Why4QuantumScape (NYSE:QS) Shares Down 6.4% - Here's What Happened5USA Rare Earth (NASDAQ:USAR) Stock Price Down 5% - Here's What Happened6Rivian Eyes Late-Year Autonomy Rollout as R2 Production Ramp Takes Center Stage7Oracle (NYSE:ORCL) Stock Rating Reaffirmed as Buy by Sanford C. Bernstein8Oracle (NYSE:ORCL) Shares Down 3.3% - Here's Why All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoNidec (OTCMKTS:NJDCY) Stock Price Down 22.2% - Here's WhyMarketBeatOTCMKTS:NJDCYRead Nidec (OTCMKTS:NJDCY) Stock Price Down 22.2% - Here's Why2 hours agoEnphase Energy (NASDAQ:ENPH) Stock Jumps 4.9% - Here's What HappenedMarketBeatNASDAQ:ENPHRead Enphase Energy (NASDAQ:ENPH) Stock Jumps 4.9% - Here's What Happened2 hours agoSolid Power (NASDAQ:SLDP) Shares Climb 5.1% - Time to Buy?MarketBeatNASDAQ:SLDPRead Solid Power (NASDAQ:SLDP) Shares Climb 5.1% - Time to Buy?2 hours agomonday.com (NASDAQ:MNDY) Stock Jumps 5.1% - Still a Buy?MarketBeatNASDAQ:MNDYRead monday.com (NASDAQ:MNDY) Stock Jumps 5.1% - Still a Buy?2 hours agoHims & Hers Health (NYSE:HIMS) Stock Price Up 5.2% - What's Next?MarketBeatNYSE:HIMSRead Hims & Hers Health (NYSE:HIMS) Stock Price Up 5.2% - What's Next?2 hours agoArbutus Biopharma (NASDAQ:ABUS) Stock Jumps 5.3% - What's Next?MarketBeatNASDAQ:ABUSRead Arbutus Biopharma (NASDAQ:ABUS) Stock Jumps 5.3% - What's Next?2 hours agoVor Biopharma (NASDAQ:VOR) Stock Jumps 5.3% - Here's What HappenedMarketBeatNASDAQ:VORRead Vor Biopharma (NASDAQ:VOR) Stock Jumps 5.3% - Here's What Happened2 hours agoBraze (NASDAQ:BRZE) Shares Climb 5.4% - Time to Buy?MarketBeatNASDAQ:BRZERead Braze (NASDAQ:BRZE) Shares Climb 5.4% - Time to Buy?2 hours agoEtsy (NYSE:ETSY) Shares Up 5.5% - Here's WhyMarketBeatNYSE:ETSYRead Etsy (NYSE:ETSY) Shares Up 5.5% - Here's Why2 hours agoGRAIL (NASDAQ:GRAL) Stock Price Up 5.5% - Time to Buy?MarketBeatNASDAQ:GRALRead GRAIL (NASDAQ:GRAL) Stock Price Up 5.5% - Time to Buy?2 hours agoC3.ai (NYSE:AI) Stock Jumps 5.5% - Here's WhyMarketBeatNYSE:AIRead C3.ai (NYSE:AI) Stock Jumps 5.5% - Here's Why2 hours agoRamaco Resources (NASDAQ:METC) Stock Price Up 5.7% - Should You Buy?MarketBeatNASDAQ:METCRead Ramaco Resources (NASDAQ:METC) Stock Price Up 5.7% - Should You Buy?2 hours agoREalloys (NASDAQ:ALOY) Stock Jumps 5.7% - What's Next?MarketBeatNASDAQ:ALOYRead REalloys (NASDAQ:ALOY) Stock Jumps 5.7% - What's Next?2 hours agoMP Materials (NYSE:MP) Stock Jumps 5.8% - Still a Buy?MarketBeatNYSE:MPRead MP Materials (NYSE:MP) Stock Jumps 5.8% - Still a Buy?2 hours agoSnap (NYSE:SNAP) Stock Price Up 5.9% - What's Next?MarketBeatNYSE:SNAPRead Snap (NYSE:SNAP) Stock Price Up 5.9% - What's Next?2 hours agoMongoDB (NASDAQ:MDB) Shares Climb 6% - Here's What HappenedMarketBeatNASDAQ:MDBRead MongoDB (NASDAQ:MDB) Shares Climb 6% - Here's What Happened2 hours agoRocket Lab (NASDAQ:RKLB) Stock Jumps 6.2% - Here's WhyMarketBeatNASDAQ:RKLBRead Rocket Lab (NASDAQ:RKLB) Stock Jumps 6.2% - Here's Why2 hours agoSatellogic (NASDAQ:SATL) Stock Jumps 6.2% - Here's What HappenedMarketBeatNASDAQ:SATLRead Satellogic (NASDAQ:SATL) Stock Jumps 6.2% - Here's What Happened2 hours agoRumble (NASDAQ:RUM) Shares Up 6.2% - Time to Buy?MarketBeatNASDAQ:RUMRead Rumble (NASDAQ:RUM) Shares Up 6.2% - Time to Buy?2 hours agoTMC the metals (NASDAQ:TMC) Stock Price Up 7.6% - Here's What HappenedMarketBeatNASDAQ:TMCRead TMC the metals (NASDAQ:TMC) Stock Price Up 7.6% - Here's What Happened2 hours agoRogers (NYSE:ROG) Shares Up 8.7% - Here's WhyMarketBeatNYSE:ROGRead Rogers (NYSE:ROG) Shares Up 8.7% - Here's Why2 hours agoShattuck Labs (NASDAQ:STTK) Shares Up 11.9% - Time to Buy?MarketBeatNASDAQ:STTKRead Shattuck Labs (NASDAQ:STTK) Shares Up 11.9% - Time to Buy?2 hours agoImmatics (NASDAQ:IMTX) Sees Unusually-High Trading Volume - Still a Buy?MarketBeatNASDAQ:IMTXRead Immatics (NASDAQ:IMTX) Sees Unusually-High Trading Volume - Still a Buy?2 hours agoHemab Therapeutics (NASDAQ:COAG) Sees Unusually-High Trading Volume - Still a Buy?MarketBeatNASDAQ:COAGRead Hemab Therapeutics (NASDAQ:COAG) Sees Unusually-High Trading Volume - Still a Buy? Featured Articles and OffersHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of RisksBy Jessica Mitacek | September 24, 2026A “bloodbath” Is ComingFrom TradeSmith (Ad)Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?By Chris Markoch | September 28, 2026Chips to Bots: Qualcomm’s Agentic AI BreakoutBy Jeffrey Neal Johnson | September 23, 2026Data Centers Got the AI Hype—But Office REITs May Get the Rent HikesBy Chris Markoch | September 27, 2026The $100 Stock Behind Elon's Next MoveFrom Paradigm Press (Ad)Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-OutBy Thomas Hughes | September 29, 20263 Space Stocks to Watch as SpaceX Reshapes the Launch MarketBy Jeffrey Neal Johnson | September 25, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 168 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
